What we do

PTS specializes in the design and manufacturing of polyamino-acid based delivery systems and bring value to our delivering solutions to clinical development & commercialization of therapeutic assets.

PTS is a leader in the Design, Development & Custom Manufacturing of polyaminoacid-based Drug Substances and Drug Products (DP). Our company provides a comprehensive CMC package, including Preclinical Development, Technology Transfer, GMP Manufacturing and Fill&Finish.

Services

null

Polyamino Acid Design & Functional Proof of Concept

Our team will provide your team an extensive knowledge on polymer-biology interface to design technologies specially suited for delivering Nucleic Acids, Small Drugs and Proteins.
null

Process Development & Preclinical Batches

Flexible and agile approach to develop robust and reproducible processes to meet your specific product requirements for GLP TOX studies.
null

GMP production & regulatory support

We offer an integral solution to bring your developments from preclinical to GMP manufacturing including our support on regulatory affairs & CMC-DMF documentation.
null

Analytical Development & QC

Our QC scientists support the development of Drug Substances through the entire project life-cycle within GMP & GLP Certified Lab and qualified equipment. Equipment and skills are specially suited but not limited to method development, validation and stability studies.

Testimonials

News

Arcline Investment Management Acquires Polypeptide Therapeutic Solutions

Arcline Investment Management (“Arcline”), a growth-oriented private equity firm with $4.3 billion of cumulative capital commitments, today announced the acquisition of Polypeptide Therapeutic Solutions, S.L. (“PTS” or “the Company”) from Columbus Venture Partners.   PTS is a leading GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications, including mRNA, DNA, cell therapies,…

PTS se apoya en IVACE y FEDER para su digitalización

Polypeptide Therapeutic Solutions, S.L. ha desarrollado con éxito entre 2017 y 2020 dos proyectos denominados “IMPLANTACIÓN DE NUEVAS TECNOLOGÍAS ORIENTADAS A LA OBTENCIÓN, CONTROL Y GESTIÓN DE DATOS ANALÍTICOS” y “IMPLANTACIÓN DE UN NUEVO ERP IN CLOUD PARA LA GESTIÓN DE DIFERENTES ÁREAS DE LA EMPRESA DE FORMA CENTRALIZADA”, para los que ha contado con…

EU Horizon2020 project: BIOMOLMACS

Innovative Training Networks (ITN) Call: H2020-MSCA-ITN-2019   The main aim of the project BIOMOLMACS is to establish a multidisciplinary training network on the emerging topic of molecular machines. In the last decades, great efforts have been spent on the development of synthetic strategies for the creation of molecular machines, and these efforts have been acknowledged…

Events

11th American DDF Summit (Boston)

  The 2021 Hybrid Summit covers both small molecules and biologics, new technologies, concepts and case studies in areas such as: Formulation design for poorly soluble compounds The potential of nanotechnology for better deliverability The latest controlled released technologies Improving patient compliance by harnessing data and the latest smart device technology Optimising formulations for continuous manufacturing Overcoming the blood brain barrier and challenges in oral delivery of biologics Reformulation and biosimilars   Know moreBook a…

Partnership Opportunities in Drug Delivery (PODD)

  Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs.   Know moreBook a meeting  

CRS Virtual Annual Meeting

  The year’s premier event in delivery science & technology   Know moreBook a meeting  

Drug Delivery West

  Next Frontiers in Drug Delivery   Know moreBook a meeting  

BIO-Europe Spring Digital

  Focused and efficient partnering at BIO-Europe Spring Digital   Know moreBook a meeting  

Contact us